Abstract
A double volume exchange transfusion (DVET) is an important, if infrequently performed, intervention to acutely lessen the total serum bilirubin (TSB) and reduce the extravascular CNS bilirubin exposure when neonatal hyperbilirubinemia poses a neurotoxicity risk. The current analysis based on the seminal works of Valaes, and Sproul and Smith, predicts that a DVET blood product of lower hematocrit (~40%) via its greater plasma volume and corresponding higher albumin content optimizes the benefits of an DVET in several ways. First, by augmenting bilirubin clearance from the extravascular space and thereby further reducing the CNS bilirubin exposure, second, by favorably positioning the intravascular albumin-bilirubin binding capacity at DVET completion to accommodate additional bilirubin equilibration and rebound hyperbilirubinemia post-exchange, and third by correcting anemia if present.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Valaes T. Bilirubin distribution and dynamics of bilirubin removal by exchange transfusion. Acta Paediatr. 1963;52 Suppl 149:1–117.
Sproul A, Smith L. Bilirubin equilibration during exchange transfusion in hemolytic disease of the newborn. J Pediatr. 1964;65:12–26.
Wong ECC, Punzalan RC. Neonatal and pediatric transfusion practice. In: Cohn CS, Delaney M, Johnson ST, Katz LM, editors. AABB technical manual. 20th ed. Bethesda, MD: AABB; 2020, p. 673–704.
Sinkin RA, Chisholm CA. Perinatal Continuing Education Program (PCEP) book 4: specialized newborn care. 4th ed. Itasca, IL: American Academy of Pediatrics; 2021, p. 25.
Klein HG, Anstee DJ. Haemolytic disease of the fetus and the newborn. In: Klein HG, Anstee DJ, editors. Mollison’s blood transfusion in clinical medicine. 12th ed. West Sussex, UK: John Wiley & Sons, Ltd; 2014, p. 303–55.
Weaving G, Batstone GF, Jones RG. Age and sex variation in serum albumin concentration: an observational study. Ann Clin Biochem. 2016;53:106–11.
Amin SB. Bilirubin binding capacity in the preterm neonate. Clin Perinatol. 2016;43:241–57.
Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, et al. Clinical practice guideline. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks gestation. Pediatrics. 2022;150:e2022058859.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Watchko, J.F. Little known and less understood: the benefits of a lower hematocrit (~40%) in reconstituted blood for double volume exchange transfusion. J Perinatol 43, 1446–1448 (2023). https://doi.org/10.1038/s41372-023-01674-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-023-01674-9